InMed Pharmaceuticals (INM) Net Margin Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Net Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,566.00 |
| Sep 30, 2025 | -2,150.00 |
| Jun 30, 2025 | 5,033.00 |
| Mar 31, 2025 | 14,266.00 |
| Dec 31, 2024 | -11,244.00 |
| Sep 30, 2024 | 14,861.00 |
| Jun 30, 2024 | -13,590.00 |
| Mar 31, 2024 | 4,617.00 |
| Dec 31, 2023 | 32,742.00 |
| Sep 30, 2023 | 81,296.00 |
| Jun 30, 2023 | 151,431.00 |
| Mar 31, 2023 | 38,618.00 |
| Dec 31, 2022 | 116,899.00 |